Also known as: Hospital Acquired Bacterial Pneumonia (HABP) / Pneumonia, Hospital Acquired / Hospital-acquired bacteral pneumonia / Hospital-acquired Pneumonia (HAP) / Pneumonia Hospital Acquired / Hospital Acquired Pneumonia (HAP) / Nosocomial Pneumonia (NP) / Hospital-acquired bacterial pneumonia / Hospital Acquired Pneumonia / Hospital Acquired Bacterial Pneumonia / Pneumonia, Hospital-Acquired / Hospital-Acquired Pneumonia / Nosocomial pneumonia (disorder) / Healthcare associated pneumonia / Healthcare-Associated Pneumonia / Pneumonia, unspecified organism / Lung inflammation / Pneumonia / Pneumonia (disorder) / Pneumonia NOS / Pulmonitis / Unspecified bacterial pneumonia / Pneumonia, Bacterial / Bacterial pneumonia (disorder) / Pneumonia bacterial / Bacterial pneumonia, unspecified / Pneumonia bacterial NOS
|An aminoglycoside used to treat infections caused by more resistant strains of Gram negative bacteria and some Gram positive bacteria.
|A non-β-lactam β-lactamase inhibitor used in combination with ceftazidime for the treatment of complicated intra-abdominal infections, complicated urinary tract infections, and hospital or ventilator-acquired pneumonia.
|A cephalosporin antibiotic used in complicated urinary tract infections.
|An injected broad-spectrum third-generation cephalosporin beta-lactam antibiotic used to treat or prevent a variety of bacterial infections, including pneumonia, gynecological infections, bone and joint infections, and septicemia, among others.
|A cephalosporin antibiotic used to treat both community and hospital-acquired pneumonia caused by susceptible bacteria.
|A cephalosporin antibiotic used to treat complicated intra-abdominal infections in combination with metronidazole, complicated urinary tract infections, and hospital-acquired pneumonia.
|A second generation fluoroquinolone used to treat various susceptible bacterial infections.
|A penicillin antibiotic combined with tazobactam to treat piperacillin-resistant, piperacillin/tazobactam susceptible, β-lactamase generating strains of several bacteria.
|An beta-lactamase inhibitor antibiotic combined with other antibiotics to treat a variety of susceptible bacterial infections.
|A beta lactamase inhibitor administered with antibiotics such as piperacillin and ceftolozane to prevent their degradation, resulting in increased efficacy.
|A glycopeptide antibiotic with a similar mechanism of action and spectrum of activity to vancomycin used to treat various infections caused by gram-positive bacteria.
|An antibacterial agent used in the treatment of complicated skin and skin structure infections and types of hospital-acquired bacterial pneumonia.
|An antibiotic used to treat gonorrhea and chlamydia.